Tumor-infiltrating CD8⁺ T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited-stage small cell esophageal carcinoma.

ABSTRACT:

SUBMITTER: Zhang Z 

PROVIDER: S-EPMC8236121 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature